Diagnostic implications and correlates of plasma ADA2 activity and ADA2 variants.
              
            
            
  
    
      
        Yue J, LeSon CE, Rimland CA, Brodeur K, Weng R, Hsu EE, Lam MT, Meyer M, Okada S, Hsu ALD, Alhezam MA, Perron MM, Halyabar O, Dedeoglu F, Nigrovic PA, Shimamura A, Rowe RG, Cooper MA, Vogel TP, Gillispie-Taylor M, Peterson R, Lin C, Nowicki KD, Dollerschell K, Nakano TA, Labrosse R, Cochino AV, Ioan A, Oliveira Mendonca L, Barros SF, Kalil J, Rojas JP, Kuan AD, Sobel ES, Moussa T, Lee SSM, Koh LW, Khan A, Sutnga S, Khubchandani R, Shoman W, El Chazli Y, Pinto B, Kavadichanda C, Abraham RS, Sun X, Zhou Q, Naidu G, Sharma A, Esperanzate C, Kastner DL, Aksentijevich I, Kelly SJ, Hershfield M, Tarrant TK, Lee PY.
        
      
    
    Yue J, et al. Among authors: lee ssm.
    Arthritis Rheumatol. 2025 Oct 28. doi: 10.1002/art.43412. Online ahead of print.
    Arthritis Rheumatol. 2025.
  
  
  PMID: 41147740